Development and Evaluation of Ontogeny Functions of the Major UDP‐Glucuronosyltransferase Enzymes to Underwrite Physiologically Based Pharmacokinetic Modeling in Pediatric Populations

Documenti analoghi

• Prediction of Pediatric Pharmacokinetics for CYP3A4 Metabolized Drugs: Comparison of the Performance of Two Hepatic Ontogeny Within a Physiologically Based Pharmacokinetic Model
  di: Marc Codaccioni, et al.
  Pubblicazione: (2024)
• Physiologically Based Pharmacokinetic Modeling of Vancomycin and its Comparison with Population Pharmacokinetic Model in Neonates
  di: Ailing Cao, et al.
  Pubblicazione: (2024)
• Physiologically Based Pharmacokinetic Modeling of Lemborexant: Exploration of Doses for Populations with Hepatic Impairment
  di: Wanhong Wu, et al.
  Pubblicazione: (2025)
• Synergistic and Additive Inhibition of UDP‐Glucuronosyltransferase 1A9 by Endogenous and Foodborne Inhibitors
  di: Ruixue Li, et al.
  Pubblicazione: (2024)
• Physiologically Based Pharmacokinetic/Pharmacodynamic Model for Secukinumab: Dose Exploration in Pediatric Patients with Plaque Psoriasis
  di: Liu Zhiwei, et al.
  Pubblicazione: (2025)